azithromycin dihydrate

FDA Drug Profile — Zithromax, azithromycin dihydrate

azithromycin dihydrate is listed in the FDA National Drug Code directory with 31 NDC codes, marketed under brand names including Zithromax, azithromycin dihydrate. Available dosage forms: powder, for suspension, powder, tablet, film coated, injection, powder, lyophilized, for solution, tablet.

Drug details

Generic Name
azithromycin dihydrate
Brand Names
Zithromax, azithromycin dihydrate
Application Number
NDA050710
Sponsor
Pfizer Laboratories Div Pfizer Inc
NDC Codes
31
Dosage Forms
POWDER, FOR SUSPENSION, POWDER, TABLET, FILM COATED, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, TABLET
Routes
ORAL, INTRAVENOUS
Active Ingredients
AZITHROMYCIN DIHYDRATE

Indications and Usage

1 INDICATIONS AND USAGE Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Azithromycin is a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria: Mycobacterial Infections ( 1.2 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ( 1.3 ) 1.2 Mycobacterial Infections Prophylaxis of Disseminated Mycobacterium avium complex (MAC) Disease Azithromycin tablets, taken alone or in combination with rifabutin at its approved dose, are indicated for the prevention of disseminated MAC disease in persons with advanced HIV infection. [see Dosage and Administration (2) ] Treatment of Disseminated MAC Disease Azithromycin tablets, taken in combination with ethambutol, are indicated for the treatment of disseminated MAC infections in persons with advanced HIV infection . [see Use in Specific Populations (8.4) and Clinical Studies (14.1) ] 1.3 Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin tablets and other antibacterial drugs, azithromycin tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.